Scopus BioPharma SCPS
$ 0.18
-48.37%
Quarterly report 2023-Q2
added 08-11-2023
Country |
USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Morris C. Laster |
Employees in the company |
1 |
Shares |
21.1 M |
Market Cap[1] |
$ 3.71 M |
EBITDA (LTM) |
$ -12.6 M |
P/E (LTM) |
-0.45 |
P/S (LTM) |
- |
EPS (LTM) |
-0.4 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.